BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2749968)

  • 21. [Effects of argon laser pan-retinal photocoagulation on the electrooculogram (first results from 12 eyes with diabetic retinopathy)].
    Berard PV; Boyer R; Kaphan G; Aubert L; Rimey J
    Bull Soc Ophtalmol Fr; 1979; 79(11-12):1077-86. PubMed ID: 575986
    [No Abstract]   [Full Text] [Related]  

  • 22. The Effects of Diabetic Retinopathy and Pan-Retinal Photocoagulation on Photoreceptor Cell Function as Assessed by Dark Adaptometry.
    Bavinger JC; Dunbar GE; Stem MS; Blachley TS; Kwark L; Farsiu S; Jackson GR; Gardner TW
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):208-17. PubMed ID: 26803796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between the method of xenon photocoagulation and the state of the retina in patients with diabetic retinopathy].
    Zygulska-Machowa H; Mirkiewicz-Sieradzka B; Romanowska B
    Klin Oczna; 1985 Feb; 87(2):76-8. PubMed ID: 4032976
    [No Abstract]   [Full Text] [Related]  

  • 24. Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathy.
    Gurelik G; Coney JM; Zakov ZN
    Ophthalmic Surg Lasers Imaging; 2004; 35(2):94-102. PubMed ID: 15088818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Visual function following pan-retinal argon laser photocoagulation in diabetic retinopathy].
    Lavergne G; Ramioul-Gougnard E
    Bull Soc Belge Ophtalmol; 1980; (188-189):173-80. PubMed ID: 7195756
    [No Abstract]   [Full Text] [Related]  

  • 26. [Findings of electrophysiological studies at various stages of combined surgical treatment of patients with proliferative diabetic retinopathy].
    Glinchuk IaI; Kuman IG; Mironova EM; Deev LA; Pletnikova NK
    Vestn Oftalmol; 1989; 105(1):36-40. PubMed ID: 2718308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenon arc photocoagulation of proliferative diabetic retinopathy (a review of 2688 consecutive eyes in the format of the diabetic retinopathy study--DRS).
    Okun E; Johnston GP; Boniuk I; Arribas N; Escoffery RF; Grand MG
    Trans Am Ophthalmol Soc; 1983; 81():229-45. PubMed ID: 6676970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5.
    Dev Ophthalmol; 1981; 2():248-61. PubMed ID: 7262408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary results of laser coagulation of the retina in the treatment of diabetic retinopathy in pregnant women].
    Mirkiewicz-Sieradzka B; Romanowska B; Kalita J; Sieradzki J
    Klin Oczna; 1992; 94(5-6):147-8. PubMed ID: 1453676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated perimetric changes following panretinal photocoagulation in diabetic retinopathy.
    Khosla PK; Gupta V; Tewari HK; Kumar A
    Ophthalmic Surg; 1993 Apr; 24(4):256-61. PubMed ID: 8321507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of pan-retinal argon laser coagulation in 100 cases of diabetic retinopathy].
    Coscas G; Soubrane G; Chaine G
    Bull Soc Ophtalmol Fr; 1978; 78(8-9):597-9. PubMed ID: 571768
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of laser spot diameter on the reproducibility of visual field analysis in diabetic patients with upper temporal retinal vein occlusion.
    Akar Y; Apaydin KC; Metinsoy M
    Ophthalmologica; 2008; 222(2):64-8. PubMed ID: 18303224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Margolis R; Singh RP; Bhatnagar P; Kaiser PK
    Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Personal experience in the treatment of proliferative diabetic retinopathy using an argon laser].
    Chrapek O; Rehák J
    Cesk Slov Oftalmol; 2001 Jul; 57(4):244-9. PubMed ID: 11512438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of diabetic macular edema: a comparison between argon and dye lasers.
    Karacorlu S; Burumcek E; Karacorlu M; Arslan O
    Ann Ophthalmol; 1993 Apr; 25(4):138-41. PubMed ID: 8484655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications for argon laser treatment of diabetic ischemic retinopathy].
    Haut J; Van Effenterre G; Monin C; M'Rad A
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1375-6. PubMed ID: 3581360
    [No Abstract]   [Full Text] [Related]  

  • 37. [Panretinal photocoagulation and proliferative diabetic retinopathy. Results of a long-term prospective study (2d report)].
    Chaine G; Zerah I; Coscas G
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1369-72. PubMed ID: 2438060
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrophysiologic studies before and after laser panphotocoagulation in diabetic retinopathy. I. Early results].
    Palacz O; Sylwestrzak Z; Oszczyk U
    Klin Oczna; 1988 Sep; 90(9):320-2. PubMed ID: 3246877
    [No Abstract]   [Full Text] [Related]  

  • 39. [Does combined pancreas-kidney transplantation modify diabetic retinopathy in type-1 diabetic patients?].
    Meyer-Schwickerath E; Scheider A; Thurau SR; Ulbig M; Landgraf R; Kampik A; Land W
    Ophthalmologe; 1993 Jun; 90(3):283-8. PubMed ID: 8334333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
    Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
    Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.